Burkitt’s lymphoma of the right colon in a young man
DOI:
https://doi.org/10.24950/rspmi.1017Keywords:
Burkitt´s Lymphoma, c-myc gene, Epstein-Barr virus, Hyper-CVAD regimenAbstract
Burkitt´s Lymphoma is a high-grade B-cell non-Hodgkin’s lymphoma uncommon in adults. It includes three main types: the sporadic form, the endemic form and an immunodeficiency related one.
It was the first tumor to be proven as associated with a virus (Epstein-Barr) and a chromosomal translocation, with well-known
consequences as deregulation of the oncogene, c-myc.
A case of a 23-year-old black male, from São Tomé e Principe,
admitted to hospital due to abdominal pain, mass in the right flank,
increased abdominal volume and periods of diarrhea alternating
with constipation is described.
After running some tests, he was diagnosed with Stage III Burkitt´s
lymphoma and we started Hyper-CVAD regimen in 8 cycles
Downloads
References
Leval L. and. Hasserjian R. P, “Diffuse large B-cell lymphomas and burkitt lymphoma,” Hematology/Oncology Clinics of North America 2009; 23(4): 791–827.
God J., Haque A., Burkitt Lymphoma: Pathogenesis and Immune Evasion,Journal of Oncology 2010; 2010: 516047.
Magrath I., Venkatesh H, Gascoyne R. Chapter 30 Burkitt’s Lymphoma. In Mauch Peter M.ed. Non-Hodgkin’s Lymphomas. Lippincott Williams & Wilkins; 1 edition 2003: 496-477.
Chehab, B., Schultz T., Nassif I., Adult Burkitt-like lymphoma of the colon: acase report and a review of the literature; Gastrointestinal endoscopy journal 2008; 67(7):1204-1206.
Kristie A. Blum, Gerard Lozanski, and John C. Byrd; Adult Burkitt leukemia and lymphoma; The American Society of Hematology 2004; 104(10): 3009-3020.
Ferry J., Burkitt’s Lymphoma: Clinicopathologic Features and Differential Diagnosis; The Oncologist, 2006; 11(4): 375-383.
Boerma, EG, van Imhoff, GW, Appel, IM, et al. Gender and age-related differences in Burkitt lymphoma-epidemiological and clinical data from The Netherlands. Eur J Cancer 2004; 40(18): 2781-2787.
Wayne A., Wilson W. Burkitt’s and Lymphoblastic Lymphomas. In Sweetencham J, Williams M. eds. Lymphoma, pathology, diagnostic and treatment; Cambridge Medicine 2007: 182-199
Armitage, JO, Weisenburger, DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol 1998; 16(8): 2780-2795.
Martin J. Allday; How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt’s lymphoma?; Seminars in Cancer Biology 2009; 19(6); 366-376.
Burkitt, D. A children’s cancer dependent on climatic factors. Nature 1962;194:232-234.
Aster J. Doenças de leucócitos, gânglios, baço e timo. In Abbas A.,Fausto N. eds. Robbins e Cotran - Bases Patológicas das Doenças.
Elsevier 2004: 695-745.
Wong M, Eu K. Primary colorectal lymphomas. Colorectal Dis 2006;8:586-591.
Carvalho L.,Mallmann A.,e tal. Linfoma do cego, relato de caso, Brasil Coloproct 2000; 20:172-174.
Glick, DD, Soule, EH. Primary malignant lymphoma of colon or appendix. Report of 27 cases. Arch Surg 1966;92:144-151.
Perry, PM, Cross, RM, Morson, BC. Primary malignant lymphoma of the rectum (22 cases). Proc R Soc Med 1972; 65:72..
Bellan, C, Lazzi, S, Hummel, M, et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 2005; 106(3): 1031-1036.
Hecht J, Aster J. Molecular biology of Burkitt’s lymphoma. J Clin Oncol.2000; 18(21):3707-3721.
Gerbitz A, Mautner J, Geltinger C, et al. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt’s lymphoma. Oncogene.1999; 18(9):1745-1753.
Photo image source Gregory Schuler, NCBI,NLM,NIH: http://www.ncbi.nlm.nih.gov/books/NBK22257
Queiroga,E; Gualco G et al, Viral Studies in Burkitt Lymphoma: Association With Epstein-Barr Virus but Not HHV-8; American Journal of Clinical Pathology. 2008;130(2): 186-192.
Magluta E; Klumb C;Ttreatment resistance in Burkitt’s lymphoma: Is it associated with specific mutations of the TP53 gene?; Revista brasileira de Hematologia e Hemoterapia 2008; 30(1): 41-46.
Photo image by Dr. Louis Staudt; Gene Expression Profiling Distinguishes Lymphomas; NIH:http://www.nih.gov/researchmatters/june2006/06092006lymphoma.htm
Photo image source The Stanford Cytopathology Service; Stanford School of Medicine: http://cytopathology.stanford.edu/
Diebold J, Jaffe ES, Raphael M, Warnke RA. Burkitt lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardimiman JW. WHO classification of tumours. Tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001: 181-184.
Broyde A., Boycov O., Strenov Y., Okon E., Shpilberg O., Bairey O.; Role and prognostic significance of the Ki-67 index in non-Hodgkin’s lymphoma; American Journal of Hematology 2009;84(6): 338-343.
Fermé C,Vanel D., Ribrag V, Girinski T; Role of imaging to choose treatment; Cancer Imaging 2005: 5 Spec No A:S113-119.
Murphy SB. Childhood non-Hodgkin lymphom. N Engl J Med 1978; 299:1446–1448.
Foon,K., Ghobrial,I., Geskin,L. et al. The Non-Hodgkin Lymphomas. In Lichtman, M., Beutler, E., Kipps,T. et al(eds.).Williams Hematology- 7th edition. New York, New York: The McGraw-Hill Companies 2006: 1407-1461.
www.uptodate.com
Bishop, PC, Rao, VK, Wilson, WH. Burkitt’s lymphoma: molecular pathogenesis and treatment. Cancer Invest 2000; 18(6):574-583.
Kantarjian, HM, O’Brien, S, Smith, TL, et al. Results of treatment with hyperCVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000; 18:547.
Thomas, DA, Cortes, J, O’Brien, S, et al. Hyper-CVAD program in Burkitt’stype adult acute lymphoblastic leukemia. J Clin Oncol 1999; 17:2461.
Hoelzer, D, Ludwig, WD, Thiel, E, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87:495.
Nademanee, A, Molina, A, O’Donnell, MR, et al. Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group. Blood 1997; 90:3844.
Song, KW, Barnett, MJ, Gascoyne, RD, et al. Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma. Br J Haematol 2006; 133(6):634-637.
Van Imhoff, GW, van der Holt, B, MacKenzie, MA, et al. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia 2005; 19:945.
Dunleavy K, Pittaluga S, Janik J, et al. Novel treatment of Burkitt lymphomawith dose-adjusted EPOCH-rituximab: preliminary results showing excellent outcome (abstract). Blood 2006;108:774ª.
Cheson, BD, Pfistner, B, Juweid, ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25(5): 579-586.
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
